Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2021
2020
Profitability Metrics
Gross Margin
33.76%
Operating Margin
20.74%
Net Margin
15.92%
Efficiency Metrics
Revenue per Expense Ratio
1.28
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
20.74%
Income Tax Rate
-18.93%
EPS
2.0100000000
Balance Sheet Analysis
Current Ratio
1.97
Cash Ratio
0.43
Working Capital
$2.08B
Debt to Equity
0.80
Debt to Assets
33.35%
Equity Ratio
41.89%
Cash Flow Analysis
Operating Cash Flow Ratio
9.87%
Free Cash Flow Ratio
7.93%
CapEx to Revenue
1.94%
Dividends Paid
$279.50M
Stock Buybacks
$601.70M
Total Shareholder Returns
$881.20M
Cash Position Change
-30.34%
Key Takeaways (2024 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
21.25%
Net Income
25.73%
EPS
24.07%
Operating Income
23.34%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
24.53%
Operating Cash Flow
0.00%
Free Cash Flow
0.00%
Balance Sheet Health
Assets
0.00%
Debt
0.00%
Book Value per Share
0.00%
Inventory
0.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
0.91%
Long Term Trends
3Y Revenue/Share
39.03%
5Y Revenue/Share
82.95%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%